Xellia
| Company type | Aktieselskab |
|---|---|
| Industry | Pharmaceuticals, health care[1] |
| Founded | 1958[1] |
| Headquarters | Copenhagen, Denmark[1] |
| Website | http://www.xellia.com |
Xellia ApS is a Danish multinational pharmaceutical and life sciences company headquartered in Copenhagen[1] specialized in the production of anti-biotics, including Vancomycin[2] and Bacitracin.[3]
The company's US base of operations is in Buffalo Grove, Illinois,[4][5] with additional facilities in Ohio, and North Carolina.[6][7] In 2018, Xellia's sales in the United States accounted for 60% of its total revenue.[5]
Products[edit]
The company's main output is bulk drug chemicals which are wholesaled to other companies for packaging and distribution. Recently some prepackaged goods have been produced.
Active drug substances manufactured are:[8]
Discontinued products[edit]
Previously the company also produced:
| Ingredient | Produced |
|---|---|
| Neomycin | 1952-? |
| Tetracycline | 1961-? |
Partnerships[edit]
In 2019, Xellia partnered with Civica Rx to produce generic Vancomycin and Daptomycin. The partnership's stated aim is to remedy chronic drug shortages that have affected the American pharmaceutical market.[4][19][20][21][22]
China-US Trade War[edit]
Xellia has been discussed as a potential alternative to Chinese companies for anti-biotic primary ingredients in the context of the China-United States trade war.[23]
See also[edit]
References[edit]
- ^ a b c d "Xellia Pharmaceuticals ApS". Bloomberg. 2019-05-15. Retrieved 15 July 2019.
- ^ "VANCOMYCIN HYDROCHLORIDE". U.S. National Library of Medicine. 2019-05-15. Retrieved 10 September 2019.
- ^ "BACITRACIN- bacitracin injection". U.S. National Library of Medicine. Retrieved 10 September 2019.
- ^ a b "Xellia to produce Civica antibiotics". Chicago Daily Herald. 2019-05-15. Retrieved 15 July 2019.
- ^ a b "Danish pharmaceutical company picks Chicago area for new office". Chicago Business Journal. Retrieved 15 July 2019.
- ^ "Will China Save the American Economy?". The Atlantic. 2017-06-27. Retrieved 15 July 2019.
- ^ "Denmark-based pharmaceuticals company acquires Raleigh manufacturing plant". Triangle Business Journal. Retrieved 21 July 2019.
- ^ produktet listen er hentet fra Api på xellia.com Archived 2015-08-27 at the Wayback Machine 15. august 2014 og supplert med informasjon fra Vår arv Archived 2015-08-24 at the Wayback Machine hentes samme dag
- ^ a b c d e f g h i j "Godkjent eller ikke godkjent – hvilke statuser kan et legemiddel ha?". Archived from the original on 28 August 2016. Retrieved 27 August 2016.
- ^ a b "Legemiddelsøk". Retrieved 27 August 2016.
- ^ "Legemiddelsøk". Retrieved 27 August 2016.
- ^ "Legemiddelsøk". Retrieved 27 August 2016.
- ^ "Legemiddelsøk". Retrieved 27 August 2016.
- ^ "Legemiddelsøk". Retrieved 27 August 2016.
- ^ "Legemiddelsøk". Retrieved 27 August 2016.
- ^ "Legemiddelsøk". Retrieved 27 August 2016.
- ^ "Legemiddelsøk". Retrieved 27 August 2016.
- ^ "Legemiddelsøk". Retrieved 4 September 2016.
- ^ "Two crucial antibiotics are the first products of Utah's new nonprofit drug company". Salt Lake Tribune. Retrieved 15 July 2019.
- ^ "Drugmaker Created To Reduce Shortages And Prices Unveils Its First Products". NPR. Retrieved 15 July 2019.
- ^ Evans, Melanie (15 May 2019). "Hospital Drug-Making Venture Picks Antibiotics as First Products". Wall Street Journal. Retrieved 15 July 2019.
- ^ "Unique initiative to lower drug prices signs manufacturer". Houston Chronicle. 20 May 2019. Retrieved 22 July 2019.
- ^ "Trade War With China Threatens To Make Problems With Generic Medicine Worse". Forbes. Retrieved 15 July 2019.
